Inhibitors of human immunodeficiency virus replication

Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below: Formula (i) 记载了式I-VI的化合物，包括其药学上可接受的盐，和用于治疗人免疫缺陷病毒(HIV)感染的组合物和方法。式I例举如下：式(i)...

Full description

Saved in:
Bibliographic Details
Main Authors NGUYEN VAN N, MEANWELL NICHOLAS A, BENDER JOHN A, FRIDELL ROBERT A, LOPEZ OMAR D, BENO BRETT R, BELEMA MAKONEN, THANGATHIRUPATHY SRINIVASAN, YANG ZHONG, WANG GAN, WANG ALAN XIANGDONG
Format Patent
LanguageChinese
English
Published 06.03.2018
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below: Formula (i) 记载了式I-VI的化合物，包括其药学上可接受的盐，和用于治疗人免疫缺陷病毒(HIV)感染的组合物和方法。式I例举如下：式(i)
Bibliography:Application Number: CN201680036783